Rudi Mariën
 | This article includes a list of references, related reading, or external links, but its sources remain unclear because it lacks inline citations. (April 2021) |
Rudi Mariën is a Belgian scientist and businessman. He is chairman of the Belgian biotech company Innogenetics.
Education[edit]
Rudi Mariën obtained a degree in pharmaceutical sciences from the University of Ghent, specializing in clinical biology.
Career[edit]
On 18 July 1985, he co-founded the Belgian biotech company Innogenetics, together with Erik Tambuyzer and Hugo Van Heuverswyn and has been its chairman since then. Besides Innogenetics, he founded several clinical laboratories. He is an international centralized clinical laboratory. He is also CEO of Gengest BVBA (management company), Biovest CVA, LMA BVBA, Laboraco BVBA, and he is director of DSJ Bruxelles NV, and Oystershell NV. Rudi Mariën is a member of the American Association for Clinical Chemistry.
Sources[edit]
 | This business-related Belgian biographical article is a stub. You can help Wikipedia by expanding it. |